DK1089742T3 - Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein - Google Patents

Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein

Info

Publication number
DK1089742T3
DK1089742T3 DK99926749T DK99926749T DK1089742T3 DK 1089742 T3 DK1089742 T3 DK 1089742T3 DK 99926749 T DK99926749 T DK 99926749T DK 99926749 T DK99926749 T DK 99926749T DK 1089742 T3 DK1089742 T3 DK 1089742T3
Authority
DK
Denmark
Prior art keywords
porosis
genistein
carnitine
cheese
prevention
Prior art date
Application number
DK99926749T
Other languages
Danish (da)
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Application granted granted Critical
Publication of DK1089742T3 publication Critical patent/DK1089742T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK99926749T 1998-06-23 1999-06-17 Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein DK1089742T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98RM000417A IT1299191B1 (it) 1998-06-23 1998-06-23 Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa
PCT/IT1999/000174 WO1999066913A2 (fr) 1998-06-23 1999-06-17 Composition utilisee dans la prevention et/ou le traitement de l'osteoporose et modifications induites par le syndrome de la menopause

Publications (1)

Publication Number Publication Date
DK1089742T3 true DK1089742T3 (da) 2003-03-24

Family

ID=11406005

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99926749T DK1089742T3 (da) 1998-06-23 1999-06-17 Præparat til forebyggelse og/eller behandling af osteporose og forandringer forårsaget af menopause-syndrom, omfattende propionyl-L-carnitin og genistein

Country Status (27)

Country Link
US (1) US6335038B1 (fr)
EP (1) EP1089742B1 (fr)
JP (1) JP4430233B2 (fr)
KR (1) KR20010071541A (fr)
CN (1) CN1306434A (fr)
AR (1) AR018924A1 (fr)
AT (1) ATE228367T1 (fr)
AU (1) AU755272B2 (fr)
BR (1) BR9911440A (fr)
CA (1) CA2334875C (fr)
DE (1) DE69904172T2 (fr)
DK (1) DK1089742T3 (fr)
EE (1) EE200000741A (fr)
ES (1) ES2188177T3 (fr)
HU (1) HU224957B1 (fr)
IL (1) IL140163A0 (fr)
IS (1) IS5764A (fr)
IT (1) IT1299191B1 (fr)
MA (1) MA26655A1 (fr)
NO (1) NO20006431L (fr)
NZ (1) NZ508877A (fr)
PL (1) PL192118B1 (fr)
PT (1) PT1089742E (fr)
SK (1) SK19292000A3 (fr)
TN (1) TNSN99132A1 (fr)
TR (1) TR200003735T2 (fr)
WO (1) WO1999066913A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302863B1 (it) * 1998-11-13 2000-10-10 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante e preventiva di alterazionitrombotiche e aterosclerotiche comprendente una carnitina ed un
US6476010B2 (en) * 2000-03-10 2002-11-05 Hill's Pet Nutrition Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals
US20010039296A1 (en) * 2000-03-23 2001-11-08 Debasis Bagchi Method and composition for preventing or reducing the symptoms of menopause
US8669282B2 (en) 2000-10-31 2014-03-11 Hill's Pet Nutrition, Inc. Companion animal compositions including lipoic acid and methods of use thereof
US20020076470A1 (en) 2000-10-31 2002-06-20 Colgate-Palmolive Company Composition and method
IT1317079B1 (it) * 2000-12-21 2003-05-26 Sigma Tau Ind Farmaceuti Uso della isovaleril l-carnitina per la preparazione di un medicamentoper la prevenzione e cura dell'osteoporosi.
CN1638650A (zh) * 2001-03-09 2005-07-13 雀巢制品公司 改善与年龄有关的生理缺陷并延长寿命的组合物
MXPA03008137A (es) * 2001-03-15 2003-12-12 Roche Vitamins Ag Composicion para prevencion de osteoporosis que comprende combinacion de isoflavonas y acidos grasos poliinsaturados.
AUPR957001A0 (en) * 2001-12-19 2002-01-24 Novogen Research Pty Ltd Isoflavone conjugates, derivatives thereof and therapeutic methods involving same
JP2005524638A (ja) * 2002-02-15 2005-08-18 エヌ・ヴイ・ヌートリシア 骨粗しょう症及び肥満処置用医薬の製造におけるゲニステインの使用及びビタミンｄ及びｋと組合わせてゲニステインを含有する組成物
KR100542478B1 (ko) * 2002-08-28 2006-01-11 한경대학교 산학협력단 석류 유래 피토에스트로겐을 함유하는 건강기능식품
PT1581199E (pt) * 2002-09-09 2015-04-27 Nestec Sa Composição oralmente adiminstrável para melhorar a qualidade da pele
KR100520408B1 (ko) * 2003-03-25 2005-10-10 주식회사 태평양 비만개선용 조성물
US7582674B2 (en) * 2003-05-27 2009-09-01 Dsm Ip Assets B.V. Nutraceutical compositions and use thereof
JP2005187454A (ja) * 2003-12-05 2005-07-14 Sankyo Co Ltd ビタミンｅ含有ｌｄｌ低下剤及び／又は動脈硬化抑制剤組成物
EP1711070B1 (fr) * 2004-01-28 2015-12-09 Nestec S.A. Composition nutritionnelle conçue pour ameliorer l'etat de la peau et prevenir des maladies de la peau
WO2005074905A1 (fr) 2004-02-03 2005-08-18 Kotosugi Inc. Agent therapeutique/preventif pour l'osteoporose contenant comme composant de l'isotaxiresinol derive de taxus yunnanensis
EP2208422B1 (fr) * 2004-03-17 2015-11-25 Nestec S.A. Compositions et méthodes pour réduire ou prévenir l'obésité
CN100351248C (zh) * 2004-07-05 2007-11-28 南京大学 染料木素衍生物及其制法和用途
US8697139B2 (en) 2004-09-21 2014-04-15 Frank M. Phillips Method of intervertebral disc treatment using articular chondrocyte cells
DE102004060314A1 (de) * 2004-12-08 2006-08-31 Beiersdorf Ag Wirkstoffkombinationen aus einem oder mehreren Isoflavonoiden und Carnitin und/oder einem oder mehreren Acyl-Carnitinen
WO2006071919A2 (fr) 2004-12-29 2006-07-06 Hill's Pet Nutrition, Inc. Methodes permettant d'inhiber un declin des facultes d'apprentissage et/ou de la memoire chez les animaux
CA2593335A1 (fr) * 2005-01-10 2006-07-13 Hormos Medical Ltd. Emploi d'une lignane dans l'elaboration d'une preparation destinee a prevenir ou soulager les symptomes d'une insuffisance en oestrogenes
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
RS52735B (sr) * 2005-07-08 2013-08-30 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Primena kombinacije koja sadrži l-karnitin ili alkanoil l-karnitin, benzokvinon rastvorljiv u mastima i omega-3-polinezasićenu masnu kiselinu za pripremu dodataka ishrani ili leka za lečenje oboljenja rožnjače
EP1906912B1 (fr) 2005-07-14 2012-08-15 Hill's Pet Nutrition, Inc. Procede permettant de prolonger la vie d'animaux
CN1939534B (zh) * 2005-09-27 2010-12-01 长春金赛药业股份有限公司 含有人生长激素或人粒细胞巨噬细胞刺激因子的用于治疗损伤和溃疡的外用制剂
KR20080068850A (ko) * 2005-10-14 2008-07-24 디에스엠 아이피 어셋츠 비.브이. 레스베라트롤을 포함하는 기능성식품 조성물의 신규한 용도
US8226973B2 (en) * 2005-11-02 2012-07-24 Nestec, S. A. Isoflavone compositions for reducing accumulation of body fat in male mammals, and methods for their use
JP5227195B2 (ja) 2006-02-28 2013-07-03 ネステク ソシエテ アノニム 骨成長の誘発及び骨損失の抑制のための組成物及び方法
US20090221690A1 (en) 2006-02-28 2009-09-03 Council Of Scientific And Industrial Research Pharmaceutical Composition for the Prevention/Treatment of Bone Disorders and a Process for the Preparation Thereof
EP2004161B8 (fr) * 2006-04-12 2013-04-17 Unilever PLC Composition orale comprenant de l'adh et de la génistéine pour améliorer l'apparance cutané
PL2189155T3 (pl) * 2006-04-12 2016-07-29 Unilever Nv Doustna kompozycja o przeciwstarzeniowym działaniu na skórę
ES2391305T3 (es) * 2006-04-12 2012-11-23 Unilever N.V. Composición oral que comprende un ácido graso poliinsaturado y ácido salicílico para obtener un efecto antiinflamatorio en la piel
US8680140B2 (en) * 2006-08-02 2014-03-25 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of menopausal symptoms
US20080108696A1 (en) 2006-08-02 2008-05-08 Brinton Roberta D Phytoestrogenic Formulations for Alleviation or Prevention of Neurodegenerative Diseases
WO2008100560A2 (fr) * 2007-02-14 2008-08-21 University Of Southern California Modulateurs de récepteur d'œstrogène, compositions pharmaceutiques associées et procédés d'utilisation
AU2009292555B2 (en) 2008-09-10 2014-05-29 AGC Inc. Novel prostaglandin I2 derivative
US20110091435A1 (en) * 2008-10-24 2011-04-21 University Of Southern California Phytoestrogenic formulations for alleviation or prevention of hair loss
BRPI0921679A2 (pt) * 2008-11-11 2016-02-16 Sigma Tau Ind Farmaceuti composto útil para tratar celulite
KR101158856B1 (ko) 2009-05-12 2012-06-25 한국생명공학연구원 콩잎 추출물 또는 이의 분획물을 유효성분으로 함유하는 비만, 고지혈증, 동맥경화, 지방간, 당뇨 또는 대사증후군의 예방 또는 치료용 조성물
RU2564414C2 (ru) * 2010-03-08 2015-09-27 Какен Фармасьютикал Ко., Лтд. Новый агонист ер4
PT2582368T (pt) * 2010-06-16 2018-06-04 Alfasigma Spa Acetil-carnitina, para utilização num método para o aumento da neurogénese em tecido neuronal
WO2012011572A1 (fr) * 2010-07-23 2012-01-26 国立大学法人大阪大学 Agent thérapeutique pour insuffisance cardiaque diastolique
IT201700116392A1 (it) * 2018-04-03 2019-10-03 Composizione per somministrazione orale aventi benefico effetto sulla salute della donna in menopausa

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1275434B (it) * 1995-05-19 1997-08-07 Farmila Farma Milano Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
US5702752A (en) * 1996-03-13 1997-12-30 Archer Daniels Midland Company Production of isoflavone enriched fractions from soy protein extracts
US6139872A (en) * 1996-08-14 2000-10-31 Henkel Corporation Method of producing a vitamin product
CA2280093A1 (fr) * 1997-02-04 1998-08-06 John V. Kosbab Compositions et procedes destines a la prevention et au traitement de maladies degeneratives vasculaires

Also Published As

Publication number Publication date
IS5764A (is) 2000-12-08
NO20006431L (no) 2001-02-22
PL192118B1 (pl) 2006-09-29
DE69904172D1 (de) 2003-01-09
TR200003735T2 (tr) 2001-03-21
AU755272B2 (en) 2002-12-05
AR018924A1 (es) 2001-12-12
NO20006431D0 (no) 2000-12-15
JP4430233B2 (ja) 2010-03-10
EP1089742A2 (fr) 2001-04-11
ATE228367T1 (de) 2002-12-15
ES2188177T3 (es) 2003-06-16
MA26655A1 (fr) 2004-12-20
EE200000741A (et) 2002-04-15
WO1999066913A3 (fr) 2000-04-20
KR20010071541A (ko) 2001-07-28
JP2002518437A (ja) 2002-06-25
PL345030A1 (en) 2001-11-19
HUP0102879A3 (en) 2002-12-28
IT1299191B1 (it) 2000-02-29
NZ508877A (en) 2002-09-27
CA2334875A1 (fr) 1999-12-29
WO1999066913A2 (fr) 1999-12-29
TNSN99132A1 (fr) 2005-11-10
ITRM980417A1 (it) 1999-12-23
HU224957B1 (en) 2006-04-28
AU4390999A (en) 2000-01-10
DE69904172T2 (de) 2003-08-28
IL140163A0 (en) 2002-02-10
BR9911440A (pt) 2001-03-20
CN1306434A (zh) 2001-08-01
HUP0102879A2 (hu) 2002-03-28
CA2334875C (fr) 2009-05-12
US6335038B1 (en) 2002-01-01
ITRM980417A0 (it) 1998-06-23
EP1089742B1 (fr) 2002-11-27
SK19292000A3 (sk) 2001-08-06
PT1089742E (pt) 2003-04-30

Similar Documents

Publication Publication Date Title
EE200000741A (et) Kompositsioon osteoporoosi ja menopausi sündroomist tingitud muutuste ennetamiseks ja/või raviks
DK1085877T3 (da) Anvendelse af en sammensætning, der omfatter formoterol og budesonid, til forebyggelsen eller behandlingen af en akut tilstand af astma
DK1123284T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1427437T3 (da) Oxyntomodulin til forebyggelse eller behandling af overvægt
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
EP1390862A4 (fr) Procede d'amelioration de la fiabilite des telechargements sur des reseaux de systemes homologues
DK1173431T4 (da) Fremgangsmåde til fremstilling af citalopram
DK1632234T3 (da) (S,S)-reboxetin til behandling af kronisk træthedssyndrom
DK1143977T3 (da) 2-oxy-benzoxazinonderivater til behandling af obesitas
DK1159274T3 (da) Fremgangsmåde til fremstilling af citalopram
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1181027T3 (da) Diætetisk eller farmaceutisk præparat til anvendelse til forebyggelsen eller behandling af hyperoxaluri
DK1123313T3 (da) Fremgangsmåder og sammensætninger til forebyggelse og behandling af anæmi
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
DK1309324T3 (da) Antikonvulsive derivater egnede til behandling og forebyggelse af udvikling af type II diabetes mellitus og syndrom X
DE50002676D1 (de) Eine film-, folien- oder oblatenförmige zubereitung
DK1066056T4 (da) Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernmangel, fremgangsmåde til fremstilling af jerndextranforbindelsen og anvendelse af denne forbindelse til fremstilling af et...
DK1315709T3 (da) Aminoalkylbenzoyl-benzofuraner eller benzothiophener, fremgangsmåde til fremstilling deraf og sammensætninger indeholdende samme
DK0828019T3 (da) Sammensat vlies, fremgangsmåde til dens fremstilling og anvendelse deraf
DK199800837A (da) Anlæg til behandling af emner
IS6378A (is) Efnasambönd og samsetningar gegn dvergveirum, notkun þeirra til lyfjagerðar og efni til að framleiða þau
NO971495D0 (no) Svekkede virus og fremgangsmåte til deres fremstilling
NO20013735D0 (no) Fremgangsmåte til fremstilling av di-iso-butaner, di-iso- butener og di-n-butener fra feltbutaner
NO960272D0 (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
NO20010464D0 (no) Fremgangsmåter og sammensetninger for behandling av gastroösofrageal-reflukssyndrom